Expert Opinion on Drug Delivery 14 , 983995, (2017)
Their compounding status under federal law is still being determined: removal from the Category 2 restricted list takes effect April 23, 2026, and the FDAs Pharmacy Compounding Advisory Committee will review whether to officially clear any of them at its July 23-24, 2026 meeting
doi: 10.3389/fphar.2020.590855 Received 03 August 2020 Accepted 18 September 2020 Published 15 October 2020 Volume 11 - 2020 Edited by Efstratios Stratikos, National Centre of Scientific Research Demokritos, Greece Reviewed by Marcin Poreba, Wrocaw University of Science and Technology, Poland Akira Hattori, Kyoto University, Japan Updates Copyright 2020 Hallberg and Larhed
The variance is typically within acceptable experimental error margins
doi: 10.3389/fphys.2024.1389113 113 XuZ.JiangW.HuangW.LinY.ChanF